Skip to content

Homepage

Author: Vicore Pharma Holding

Posted Date:

July 7, 2026

Vicore Pharma to Participate in the Leerink Therapeutics Forum

Vicore Pharma Holding

July 7, 2026
Vicore Pharma Appoints Rob Slack as Chief Scientific Officer

Vicore Pharma Holding

July 6, 2026
Vicore Pharma to Commence Trading in the United States on the Nasdaq Stock Market

Vicore Pharma Holding

July 1, 2026
Vicore Pharma to Host Webcast to Discuss Buloxibutid and the Evolving IPF Treatment Landscape

Vicore Pharma Holding

June 2, 2026
Vicore Pharma to Present at the Jefferies Global Healthcare Conference

Vicore Pharma Holding

May 26, 2026
Vicore Pharma Pursues US Dual Listing, Files Registration Statement with the SEC

Vicore Pharma Holding

May 22, 2026
Vicore Pharma Elects Peter Guenter to its Board of Directors

Vicore Pharma Holding

May 8, 2026
Announcement from the Annual General Meeting of Vicore Pharma Holding AB (publ)

Vicore Pharma Holding

May 8, 2026
Interim Report January – March 2026

Vicore Pharma Holding

May 8, 2026
Vicore Pharma Announces Presentations at the 2026 American Thoracic Society International Conference

Vicore Pharma Holding

May 7, 2026

1 2